Pilot study by Brigham investigators finds that an innovative care-delivery program helped 81 percent of participants achieve blood pressure control in seven weeks
Hypertension, or high blood pressure, is a widespread clinical problem affecting nearly half of all adults. Despite the serious consequences that can result from hypertension, which puts patients at increased risk for heart attacks, strokes and other cardiovascular events, elevated blood pressures often remain untreated or undertreated for years, and the control rate for hypertension hovers at just 50 percent. Seeing opportunities for improvement, innovators and clinicians at Brigham and Women’s Hospital have developed a new home-based, care-delivery program aimed to improve hypertension control rates quickly and at significantly lower cost than traditional, office-based blood pressure programs. The new approach, piloted among 130 participants, helped 81 percent of patients bring their blood pressures under control in, on average, just seven weeks. The results of the pilot study are published this week in Clinical Cardiology.
“This is a striking result, especially given the very short time frame in which control was reached: an average of seven weeks,” said corresponding author Naomi Fisher, MD, director of the Hypertension Service and Hypertension Specialty Clinic at the Brigham. “There are a few notable health care systems that have matched or exceeded this control rate, but most clinical practices do not approach this rate of success.”
To overcome some of the challenges that clinical practices face, Fisher and colleagues combined several innovative strategies to create their program. Enrolled participants each received a Bluetooth-enabled blood pressure device that could automatically transmit the blood pressure measurements patients took at home into their electronic medical records. Patients had easy and frequent access to “patient navigators”–non-physicians who had been trained to use a clinical algorithm developed by hypertension specialists. The program enabled rapid assessment and medication dosage adjustments for the patients.
The pilot was conducted as a prospective cohort study. The team enrolled 130 patients whose blood pressure was uncontrolled (greater than 140/90 mmHg). Patients were recruited from two clinics to test efficacy in two settings: a Brigham primary care clinic (800 Huntington Ave.), and the Brigham’s Watkins Cardiovascular Clinic. All adults were eligible except pregnant women and those with advanced kidney disease. Enrolled patients were given a Bluetooth-enabled blood pressure device and taught how to use it. Patients were instructed to measure their blood pressure at home twice daily in duplicate. Medication adjustments were made every two weeks until home blood pressure was controlled at <135/85 mmHg.
The team’s next step will be to scale up the program to test its generalizability and sustainability. With this approach, the team anticipates significant cost effectiveness and cost savings, in addition to the prevention of cardiovascular events and death from treating hypertension more intensively in men and women.
“The time-honored model of treating hypertension via traditional visits to the doctor is neither effective nor sustainable,” said Fisher. “Development of innovative solutions to manage hypertension effectively and efficiently, and thus reduce the cardiovascular risk burden in larger populations, is critical. Organizations can and should develop and adopt innovative technologies to create sustainable solutions for the control of hypertension.”
The Latest on: Hypertension
via Google News
The Latest on: Hypertension
- Pulmonary Arterial Hypertension (PAH) Medicine Market to show outstanding growth by 2025|Global Key players, Type, region, manufactures on February 7, 2019 at 6:27 am
Feb 07, 2019 (Heraldkeeper via COMTEX) -- Global Pulmonary Arterial Hypertension (PAH) Medicine Market reports provide CAGR Value 2018-2025 and analysis of Top Players, Geography, End users, Applicati... […]
- Nearly Half of US Adults Have CVD — Mostly Hypertension on February 6, 2019 at 11:32 am
Nearly half of all adults in the United States in 2016 — 48% or 121.5 million — have some form of cardiovascular disease (CVD), according to the annual statistical update on heart disease and stroke f... […]
- Pulmonary Arterial Hypertension Treatment Market Reflecting a CAGR of 2.5% during 2018-2024 on February 6, 2019 at 9:29 am
Feb 06, 2019 (Heraldkeeper via COMTEX) -- New York, Feb 06, 2019: The Pulmonary Arterial Hypertension Treatment Market is segmented on the Basis of Type, Application Type and Regional Analysis. By Typ... […]
- Impaired glucose tolerance, hypertension up risk for diabetes, CVD on February 6, 2019 at 8:20 am
A study in the Journal of Diabetes showed a 25% increase in diabetes risk for every 1-mmol/L increase in 2-hour plasma glucose at baseline and a 9% increase in diabetes risk for every 10-mm Hg increas... […]
- Global Antihypertensives Market Expected to Reach $27.8 billion by 2023 – Current and Future Market Trends on February 6, 2019 at 2:45 am
The study includes a discussion of antihypertensive drugs prescribed for lowering the high blood pressure and for the treatment of pulmonary arterial hypertension (PAH). The report excludes drugs used ... […]
- Hypertension speeds diabetes progression, increases CVD risk on February 5, 2019 at 1:03 pm
Adults with impaired glucose tolerance and hypertension are at greater risk for diabetes and cardiovascular disease events than those without hypertension, according to findings published in the Journ... […]
- Loss of Teeth in Older Women Increases Hypertension Risk on February 4, 2019 at 1:44 pm
Joshua H. Gordon, a student in the MD-PhD Program, is lead author of a study showing that postmenopausal women who have experienced loss of all teeth are at higher risk of developing high blood pressu... […]
- Sphygmomanometer Market to be Driven by Rising Hypertension Cases and Cardiovascular Diseases, Industry Forecast Till 2023 | Million Insights on February 4, 2019 at 3:40 am
FELTON, California, Feb. 4, 2019 /PRNewswire/ -- The sphygmomanometer market is anticipated to grow at a CAGR of 8% during the forecast period. The diagnosis of hypertension should be purely based on ... […]
- Pulmonary hypertension linked to complications after head and neck procedures on February 1, 2019 at 11:39 pm
The findings come from what is believed to be the first study of its kind to investigate the impact of pulmonary hypertension (PHTN) on major head and neck procedures. “PHTN is a common condition whic... […]
- Seattle startup rakes in $2M for hypertension remote monitoring system on January 31, 2019 at 2:08 pm
Sentinel Healthcare, a company offering a platform for remote monitoring and management of patients with hypertension, has raised $2 million in a round led by PSL Ventures. The Seattle-based ... […]
via Bing News